Non-surgical oncology specialists conduct almost half of the sarcoma surgeries, a study revealed. Researchers from UC Davis analyzed the data of surgeries conducted over three years in 85 different academic medical centers in the United States. Careful examination revealed how just 52 percent of sarcoma surgeries were conducted by orthopedic oncologists and surgical oncologists who are actually trained to carry out complex surgical procedures, including locating the deep sarcoma tumors located within the soft tissues of the body.
According to the study, the remaining 48 percent of sarcoma surgeries were carried out by general surgeons, orthopedic surgeons and plastic surgeons, most of who did not have a post-medical degree training involving the surgical management of sarcoma tumors located deep within tissues.
AIDS/HIV Related Cancer - Kaposi's sarcoma
Kaposi Sarcoma (KS) type of cancer is generally found in people with low immunity. The symptoms are breathlessness, bleeding, red or purple spots on the body.
Kaposi Sarcoma (KS) type of cancer is generally found in people with low immunity. The symptoms are breathlessness, bleeding, red or purple spots on the body.
The statistics revealed that between the year 2007 and 2009, sarcoma surgeries were performed by 2195 general surgeons, 792 plastic surgeons, 533 surgical oncologists, 1979 general orthopedic surgeons and 83 orthopedic oncologists.
"Our findings may have significant implications for the quality of care provided to patients who undergo surgery to resect, or remove, sarcomas in the deep soft tissue of the limbs," associate professor of surgery at UC Davis and a surgical oncologist, Robert Canter, explained.
New Drug Benefits Patients With Rare Sarcoma
A novel and targeted drug developed by scientists overcomes resistance in patients with metastaticgastrointestinal stromal tumor, an uncommon and life-threatening form of sarcoma.
A novel and targeted drug developed by scientists overcomes resistance in patients with metastaticgastrointestinal stromal tumor, an uncommon and life-threatening form of sarcoma.
General surgeons performing these complex procedures could result in the need of a second surgery to remove the remaining cancer cells, thereby increasing the risk of surgical complications.
Advertisement
Understanding Of Clear Cell Sarcoma Improved By Mouse Model
Geneticists led by University of Utah Nobel Prize Laureate Mario R. Capecchi, Ph.D., have engineered mice that develop clear cell sarcoma (CCS), a significant step
Geneticists led by University of Utah Nobel Prize Laureate Mario R. Capecchi, Ph.D., have engineered mice that develop clear cell sarcoma (CCS), a significant step
Source-Medindia
New approach for treating Kaposi’s Sarcoma
A sugar-loving protein boosts the growth of Kaposi sarcoma tumors, states research published in Journal of Experimental Medicine.
A sugar-loving protein boosts the growth of Kaposi sarcoma tumors, states research published in Journal of Experimental Medicine.
